3Temesgen Z, Wright AJ. Antiretrovirals. Mayo Clin Pro, 2002,74: 1284-1301.
4Zhu S, Stravrovskaya IG, Droazda M, et al. Minocycline inhibits cyto- chrome c release and delays progression of amyotrophic lateral sclero- sis in mice. Nature ,2002,417:74-78.
5Pontieri F, Ricci A, Pellicano C, et al. Minocycline in amyotrophic lat- eral sclerosis: a pilot study. Neurol Sci,2005,26 : 285-287.
6Kriz J NM, Nguyen M ,Julien J. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis, 2003,10:268.
7Joo IS, Hwang DH, Seok JI, et al. Oral Administration of memantine prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis. J Clin Neurol,2007 ,3 :181-187.
8Chen M, Ona VO, Li M, et al. Minocycline inhibits Caspase-1 and Caspase-3 expression and delays mortality in a transgenic mouse mod- el of Huntington disease. Nat Med,2000 ,6 :797-801.
9Du Y, Ma Z,Lin S, et al. Minocycline prevents nigrostriatal dopamin- ergic neurodegeneration in the MPTP model of Parkinson' disease. Proc Natl Acad Sci U S A,2008,98:14669-14674.
10Milane A, Fernandez C, Vautier S, et al. Minocycline and riluzole brain disposition : Interactions with p-glycoprotein at the blood-brain barrier. J Neurochem,2007,103 : 164-173.
